Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	10	18	3	3	3	7
Market Cap Growth	85.77%	573.89%	7.89%	-27.33%	-47.37%	32.56%
Enterprise Value	12	21	5	4	4	7
Last Close Price	0.31	0.57	0.10	0.11	0.15	0.28
PE Ratio	5.32	11.78	-	-	13.89	-
PS Ratio	0.78	1.44	0.32	0.26	0.31	0.69
PB Ratio	0.92	1.58	0.27	0.23	0.27	0.56
P/TBV Ratio	0.94	1.62	0.29	0.25	0.29	0.59
P/FCF Ratio	15.93	-	-	2.04	-	41.89
P/OCF Ratio	11.26	-	-	1.97	24.90	19.15
EV/Sales Ratio	0.96	1.67	0.56	0.42	0.40	0.78
EV/EBITDA Ratio	11.37	34.91	-	-	8.93	-
EV/EBIT Ratio	19.13	55.85	-	-	19.59	-
EV/FCF Ratio	19.58	-	-	3.34	-	47.32
Debt / Equity Ratio	0.26	0.26	0.31	0.29	0.28	0.27
Debt / EBITDA Ratio	2.66	4.12	-	-	5.89	-
Debt / FCF Ratio	4.59	-	-	2.61	-	20.53
Net Debt / Equity Ratio	0.21	0.19	0.13	-0.06	0.05	0.01
Net Debt / EBITDA Ratio	2.40	3.60	-4.36	2.68	1.36	-0.23
Net Debt / FCF Ratio	3.65	-2.75	-0.58	-0.50	-3.40	0.89
Asset Turnover	0.84	0.67	0.50	0.53	0.57	0.51
Inventory Turnover	3.06	2.95	1.88	2.65	3.20	3.02
Quick Ratio	0.57	0.79	0.58	0.82	0.92	0.86
Current Ratio	1.07	1.06	1.09	1.12	1.21	1.14
Return on Equity (ROE)	18.14%	13.14%	-8.82%	-5.42%	3.33%	-9.57%
Return on Assets (ROA)	2.64%	1.25%	-1.90%	-1.66%	0.72%	-2.92%
Return on Invested Capital (ROIC)	4.88%	2.71%	-4.86%	-4.32%	1.62%	-6.96%
Return on Capital Employed (ROCE)	5.90%	3.20%	-5.10%	-4.30%	1.70%	-7.30%
Earnings Yield	18.79%	8.49%	-34.12%	-27.61%	7.20%	-18.00%
FCF Yield	6.28%	-4.35%	-83.72%	49.05%	-5.71%	2.39%
Buyback Yield / Dilution	-14.03%	-13.08%	-14.85%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.